Cargando…

Hypoxia inducible factors in cancer stem cells

Oxygen is an essential regulator of cellular metabolism, survival, and proliferation. Cellular responses to oxygen levels are monitored, in part, by the transcriptional activity of the hypoxia inducible factors (HIFs). Under hypoxia, HIFs regulate a variety of pro-angiogenic and pro-glycolysis pathw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heddleston, J M, Li, Z, Lathia, J D, Bao, S, Hjelmeland, A B, Rich, J N
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Minireview
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833246/ https://www.ncbi.nlm.nih.gov/pubmed/20104230 http://dx.doi.org/10.1038/sj.bjc.6605551

Ejemplares similares

Regulation of Wound Healing and Fibrosis by Hypoxia and Hypoxia-Inducible Factor-1
por: Ruthenborg, Robin J, et al.
Publicado: (2014)

Targeting A20 Decreases Glioma Stem Cell Survival and Tumor Growth
por: Hjelmeland, Anita B., et al.
Publicado: (2010)

Stem vs non-stem cell origin of colorectal cancer
por: Huels, D J, et al.
Publicado: (2015)

c-Myc Is Required for Maintenance of Glioma Cancer Stem Cells
por: Wang, Jialiang, et al.
Publicado: (2008)

Induced pluripotent stem cells free of exogenous reprogramming factors
por: Abujarour, Ramzey, et al.
Publicado: (2009)

Understanding the cancer stem cell
por: Bomken, S, et al.
Publicado: (2010)

Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells
por: Dupuis, Victoria, et al.
Publicado: (2021)

Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells
por: Lathia, Justin D., et al.
Publicado: (2011)

Stem cells of ependymoma
por: Poppleton, H, et al.
Publicado: (2007)

Cancer stem cell impact on clinical oncology
por: Toledo-Guzmán, Mariel E, et al.
Publicado: (2018)

The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression
por: Houthuijzen, J M, et al.
Publicado: (2012)

Directed Differentiation of Pluripotent Stem Cells by Transcription Factors
por: Oh, Yujeong, et al.
Publicado: (2019)

New role for ceramide in hypoxia and insulin resistance
por: Xia, Qing-Song, et al.
Publicado: (2020)

Hallmarks of cancer stem cell metabolism
por: Sancho, Patricia, et al.
Publicado: (2016)

Regulators of liver cancer stem cells
por: Liu, Kai, et al.
Publicado: (2021)

Stem cells from adipose tissue and breast cancer: hype, risks and hope
por: Bertolini, F, et al.
Publicado: (2015)

Neural Transcription Factors: from Embryos to Neural Stem Cells
por: Lee, Hyun-Kyung, et al.
Publicado: (2014)

Clinical relevance of stem cells in lung cancer
por: Romeo, Horacio Eduardo, et al.
Publicado: (2023)

Stem cells, quiescence and rectal carcinoma: an unexplored relationship and potential therapeutic target
por: Buczacki, S, et al.
Publicado: (2011)

Alternative models of cancer stem cells: The stemness phenotype model, 10 years later
por: Kaushik, Vivek, et al.
Publicado: (2021)

Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions
por: Lathia, J D, et al.
Publicado: (2011)

The Role of Hippo Pathway in Cancer Stem Cell Biology
por: Park, Jae Hyung, et al.
Publicado: (2018)

Racial disparity in colorectal cancer: Gut microbiome and cancer stem cells
por: Goyal, Sachin, et al.
Publicado: (2016)

Glyoxalase 1 as a Therapeutic Target in Cancer and Cancer Stem Cells
por: Kim, Ji-Young, et al.
Publicado: (2022)

Biological, chemical and mechanical factors regulating migration and homing of mesenchymal stem cells
por: Szydlak, Renata
Publicado: (2021)

Induced pluripotent stem cells, a giant leap for mankind therapeutic applications
por: Bragança, José, et al.
Publicado: (2019)

Skeletal muscle generated from induced pluripotent stem cells - induction and application
por: Miyagoe-Suzuki, Yuko, et al.
Publicado: (2017)

Insulin resistance in diabetes: The promise of using induced pluripotent stem cell technology
por: Elsayed, Ahmed K, et al.
Publicado: (2021)

Human-induced pluripotent stem cell-atrial-specific cardiomyocytes and atrial fibrillation
por: Leowattana, Wattana, et al.
Publicado: (2022)

Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: ‘What does not kill me strengthens me'
por: Pisco, A O, et al.
Publicado: (2015)

Chipping away at 'stemness'
por: Pyle, April D, et al.
Publicado: (2004)

Role of Fbxw7 in the maintenance of normal stem cells and cancer-initiating cells
por: Takeishi, S, et al.
Publicado: (2014)

Relationships between stem cell exhaustion, tumour suppression and ageing
por: Ruzankina, Y, et al.
Publicado: (2007)

Hypoxia-activated prodrugs: paths forward in the era of personalised medicine
por: Hunter, Francis W, et al.
Publicado: (2016)

Induced pluripotent stem cell–derived human platelets: one step closer to the clinic
por: Gekas, Christos, et al.
Publicado: (2010)

Tracing and targeting cancer stem cells: New venture for personalized molecular cancer therapy
por: Radpour, Ramin
Publicado: (2017)

Epithelial plasticity and cancer stem cells: Major mechanisms of cancer pathogenesis and therapy resistance
por: Garg, Minal
Publicado: (2017)

Emerging Role of NRF2 Signaling in Cancer Stem Cell Phenotype
por: Hallis, Steffanus P., et al.
Publicado: (2023)

Tumour–stroma interactions in colorectal cancer: converging on β-catenin activation and cancer stemness
por: Le, N H, et al.
Publicado: (2008)

Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer
por: Pallis, A G, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_i5i0gol9if0qkn1g57bgohucuj